ABPI | pharmaphorum

Saturday 19 September 2026

ABPI

Views & Analysis

NICE1

NICE methods and process review aims to create fertile groun...

The way NICE reviews new medicines is about to go through its biggest change in years – but what do the proposals mean for the future of drug development in the UK?

News

cancer_cells

Cancer services should be rebuilt after COVID disruption, ex...

There is a pressing need for a joined-up cancer strategy to reverse the impact of the COVID-19 pandemic, according to a new report from the UK’s pharma industry.

Views & Analysis

someone stressed

Stay calm and carry on: How to implement the updated ABPI co...

Don’t panic – that’s the message from one ABPI code expert who tells Amanda Barrell it’s time to take stock and prioritise.

Views & Analysis

Progress two years in and opportunities to improve over next three years

VPAS: Progress two years in and opportunities to improve ove...

In the final instalment of our series reviewing the

Views & Analysis

Achievement so far on objectives for the economy and innovation

VPAS: Achievement so far on objectives for the economy and i...

In the third part of this series taking stock of

Views & Analysis

Achievement-so-far-on-objective-on-affordability

VPAS: Achievements so far on affordability

In the second part of this series taking stock of